{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910451510103321"]
[null,null,"Titolo",null,"CDC anthrax vaccine safety & efficacy research program : interim report [[electronic resource] /] / Institute of Medicine"]
[null,null,"Pubbl/distr/stampa",null,"Washington, D.C., : National Academy Press, c2001"]
[null,null,"ISBN",null,"1-280-24804-1"]
[null,null,"Descrizione fisica",null,"1 online resource (57 p.)"]
[null,null,"Disciplina",null,"616.956"]
[null,null,"Soggetti",null,"Anthrax - Vaccination"]
[{"$nulls":4},"Vaccines - Effectiveness"]
[{"$nulls":4},"Vaccines - Safety measures"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Prepublication copy; uncorrected proofs\"."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"\"\"CDC Anthrax Vaccine Safety & Efficacy Research Program\"\"; \"\"Copyright\"\"; \"\"Contents\"\"; \"\"Preface\"\"; \"\"Acknowledgments\"\"; \"\"REVIEWERS\"\"; \"\"Executive Summary\"\"; \"\"PROJECT-SPECIFIC FINDINGS AND RECOMMENDATIONS\"\"; \"\"NCID-Directed Projects in the Research Program\"\"; \"\"Human Clinical Trial, or Part A\"\"; \"\"Animal dose ranging and challenge studies, or Part B\"\"; \"\"Assays addressing correlates of immunity, or Part C\"\"; \"\"Human Leukocyte Antigen (HLA) substudy\"\"; \"\"NIP-Directed Projects of the Research Program\"\""]
[{"$nulls":4},"\"\"Survey of knowledge, attitudes, and beliefs of military personnel about the anthrax vaccine\"\"\"\"Survey of knowledge, attitudes, and beliefs of military vaccinee providers about VAERS reporting\"\"; \"\"CDC proposal for use of the Short Form 36\"\"; \"\"Remaining components of the research program directed by the NIP\"\"; \"\"1 Introduction and Background \"\"; \"\"ANTHRAX DISEASE AND PREVENTION\"\"; \"\"Anthrax Disease\"\"; \"\"Anthrax Vaccine\"\"; \"\"VACCINE RELATED ADVERSE EVENTS\"\"; \"\"POLICY CONTEXT OF REPORT\"\"; \"\"Anthrax Vaccination Policy\"\"; \"\"CDC'S RESPONSE TO CONGRESS\"\""]
[{"$nulls":4},"\"\"2 Interim Findings and Recommendations \"\"\"\"NCID RESEARCH ACTIVITIES\"\"; \"\"Part A: Clinical Trial\"\"; \"\"CDC proposal for use of the Short Form 36\"\"; \"\"Part B: Non-human Primate Dose-Ranging and Challenge Study\"\"; \"\"Part C: Assays of Immunologic Correlates of Protection\"\"; \"\"NIP RESEARCH ACTIVITIES\"\"; \"\"Knowledge, Attitudes, and Beliefs of Military Personnel about the Anthrax Vaccine\"\"; \"\"Knowledge, "]
[{"$nulls":4},"Attitudes, and Beliefs of Vaccine Providers about VAERS Reporting\"\"; \"\"Data Mining Using the VAERS Database\"\"; \"\"Meta-Analysis of Existing Studies on the Anthrax Vaccine\"\"; \"\"REFERENCES\"\""]
[{"$nulls":4},"\"\"ACRONYMS\"\"\"\"Appendix A Study Activities \"\"; \"\"Appendix B Biographical Sketches \"\""]